Form 4: Oscar Health Officer Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Oscar Health's Chief Accounting Officer, Victoria Baltrus, sold shares to cover tax obligations from vested equity awards.

Summary

  • Victoria Baltrus, Oscar Health, Inc.'s Chief Accounting Officer, reported sales of Class A Common Stock.
  • On June 2, 2026, a total of 1,091 shares were sold at a weighted average price of $21.74 per share, with prices ranging from $21.03 to $22.02.
  • On the same date, an additional 432 shares were sold at a weighted average price of $22.45 per share, with prices ranging from $22.03 to $22.96.
  • These sales were executed pursuant to a Rule 10b5-1 instruction letter established on August 8, 2025.
  • The purpose of the sales was to satisfy the reporting person's tax withholding obligation upon the vesting of previously granted equity awards.
  • Following these transactions, Victoria Baltrus beneficially owns 214,589 shares of Class A Common Stock, which includes shares to be issued from restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine insider transaction for tax withholding purposes upon the vesting of equity awards, executed under a pre-planned arrangement.

Positives

  • The sale was made to satisfy tax withholding obligations upon the vesting of previously granted equity awards, indicating that equity compensation plans are functioning and awards are maturing.

Negatives

  • An insider, the Chief Accounting Officer, disposed of a total of 1,523 shares of Class A Common Stock.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding purposes, especially when executed under a pre-arranged Rule 10b5-1 plan, are common and generally not indicative of management's view on future company performance or broader industry trends.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine, pre-planned insider transaction for tax purposes.
  • Employees: The vesting of equity awards, which led to the tax obligation, is a positive for the employee (Victoria Baltrus) as it represents compensation realization.

Key Dates

DateDescription
August 8, 2025Date Rule 10b5-1 instruction letter was entered into.
June 2, 2026Transaction date for the sale of Class A Common Stock.
June 4, 2026Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

The reported insider sale by the Chief Accounting Officer is a routine transaction to cover tax obligations from vested equity awards, executed under a pre-arranged 10b5-1 plan. This type of transaction is not typically indicative of a change in the company's fundamental outlook or the insider's confidence, thus a 'hold' recommendation is maintained.

Keywords

Oscar Health, OSCR, Insider Transaction, Form 4, Stock Sale, Equity Awards, Tax Withholding, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.